(Q58087981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

author name string

S Y Cindy Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Stephanie Lheureux

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Katherine Karakasis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Julia V Burnier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Jeffery P Bruce

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Derek L Clouthier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Arnavaz Danesh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Rene Quevedo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Mark Dowar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Youstina Hanna

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Tiantian Li

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Lin Lu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Wei Xu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Pamela S Ohashi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Patricia A Shaw

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Amit M Oza

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Trevor J Pugh

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

language of work or name

English

0 references

publication date

31 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 May 2020

copyright license

start time

31 October 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

12 December 2020

Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients

1 reference

12 December 2020

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

1 reference

12 December 2020

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

12 December 2020

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss

1 reference

12 December 2020

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

12 December 2020

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas

1 reference

12 December 2020

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

1 reference

12 December 2020

Fast and accurate long-read alignment with Burrows-Wheeler transform

1 reference

12 December 2020

Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer

1 reference

12 December 2020

Copy number analysis identifies novel interactions between genomic loci in ovarian cancer

1 reference

12 December 2020

A framework for variation discovery and genotyping using next-generation DNA sequencing data

1 reference

12 December 2020

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

1 reference

12 December 2020

Integrated genomic analyses of ovarian carcinoma

1 reference

12 December 2020

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts

1 reference

12 December 2020

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.

1 reference

12 December 2020

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

1 reference

12 December 2020

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs

1 reference

12 December 2020

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

1 reference

12 December 2020

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2

1 reference

12 December 2020

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

1 reference

12 December 2020

GSVA: gene set variation analysis for microarray and RNA-seq data.

1 reference

12 December 2020

The genetic landscape of high-risk neuroblastoma

1 reference

12 December 2020

The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study).

1 reference

12 December 2020

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

12 December 2020

Signatures of mutational processes in human cancer

1 reference

12 December 2020

Inferring tumour purity and stromal and immune cell admixture from expression data

1 reference

12 December 2020

Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.

1 reference

12 December 2020

Integrated analysis of germline and somatic variants in ovarian cancer.

1 reference

12 December 2020

Dynamic modeling in ovarian cancer: an original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development.

1 reference

12 December 2020

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

1 reference

12 December 2020

Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers

1 reference

12 December 2020

Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack

1 reference

12 December 2020

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

1 reference

12 December 2020

Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.

1 reference

12 December 2020

Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.

1 reference

12 December 2020

TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

1 reference

12 December 2020

From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline

1 reference

12 December 2020

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

1 reference

12 December 2020

Oncotator: cancer variant annotation tool

1 reference

12 December 2020

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

12 December 2020

What have we learned from exceptional tumour responses?: Review and perspectives.

1 reference

12 December 2020

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

1 reference

12 December 2020

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.

1 reference

12 December 2020

Whole-genome characterization of chemoresistant ovarian cancer.

1 reference

12 December 2020

Ovarian cancer treatment: The end of empiricism?

1 reference

12 December 2020

Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer

1 reference

12 December 2020

High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation

1 reference

12 December 2020

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

1 reference

12 December 2020

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

1 reference

12 December 2020

Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer

1 reference

12 December 2020

1 reference

12 December 2020

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response

1 reference

12 December 2020

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

1 reference

12 December 2020

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer

1 reference

12 December 2020

A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases

1 reference

12 December 2020

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

1 reference

12 December 2020

Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition.

1 reference

12 December 2020

DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression

1 reference

12 December 2020

Who are the long-term survivors of high grade serous ovarian cancer?

1 reference

12 December 2020

Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability

1 reference

12 December 2020

10.1186/S13073-018-0590-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30382883%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference